 |
市場調查報告書
商品編碼
2102909
全球血液透析和腹膜透析市場：按產品/服務、應用、最終用戶和地區分類－預測至2031年Hemodialysis & Peritoneal Dialysis Market by Product, Modality, Disease Indication, End User, Region - Global Forecast to 2031 |
||||||
價格
2026 年全球血液透析和腹膜透析市場價值為 1,027 億美元，預計到 2031 年將達到 1,415 億美元，預測期內複合年成長率為 6.6%。
全球糖尿病和高血壓盛行率不斷上升，以及由於人口老化導致慢性腎臟病(CKD) 和末期腎功能衰竭(ESRD) 盛行率不斷上升，是市場擴張的主要驅動力。
| 調查範圍 | |
|---|---|
| 調查期 | 2026-2031 |
| 基準年 | 2025 |
| 預測期 | 2026-2031 |
| 計算單位 | 金額（10億美元） |
| 部分 | 按產品/服務、按應用、按最終用戶、按地區 |
| 目標區域 | 歐洲、北美、亞太地區、拉丁美洲、中東和非洲 |
在醫療保健系統成本控制政策和保險公司（例如美國醫療保險和醫療補助服務中心 (CMS)）的報銷機制的支持下，居家透析的普及正在穩步推進，從而擴大了居家血液透析和腹膜透析的患者群體。亞太、拉丁美洲以及中東和非洲等新興市場透析基礎設施的擴建，進一步加速了全球病患數量的成長。然而，在北美以外的一些市場，居家血液透析的高昂費用和不足的報銷阻礙了居家治療計畫的推廣。
“在預測期內，高清接入產品細分市場預計將在高清耗材中實現最高的複合年成長率。”
在血液透析耗材和用品領域，預計血液透析通路產品在預測期內將以最高的複合年成長率成長。血管通路是所有血液透析療程的必要組成部分，其產生的結構性需求在所有醫療機構中都保持一致。基於美國國家腎臟基金會KDOQI方案的臨床指南優先推薦動靜脈瘻管（AVF）的建立作為首選通路方法，這推動了相關手術數量和產品的消耗。隧道式血液透析導管作為永久性通路過渡手段的日益普及、需要長期通路管理的患者群體不斷成長，以及對一次性通路針和固定產品的需求不斷增加，都促進了該領域的成長。透析器是成長速度第二快的細分市場，也受益於高通量和中截留膜技術的臨床應用日益廣泛，這些技術與標準膜相比，能夠提高中分子清除率。
“到2025年，醫院將佔據全球血液透析和腹膜透析市場的最大佔有率。”
從終端用戶角度來看，預計到2025年，醫院將佔據全球血液透析和腹膜透析市場最大的佔有率。醫院透析中心能夠全面管理末期腎功能衰竭（ESRD）和急性腎損傷（AKI）患者的複雜臨床情況，包括新確診患者、合併嚴重併發症的患者以及需要持續腎臟替代治療的重症監護患者。醫院環境集中了專業的腎臟病醫護人員、透析設備和緊急應變基礎設施，是病患開始接受治療的天然醫療中心。雖然獨立透析中心整體上仍是最大的管道，但其運作較為分散，而醫院則承擔了大部分重症和新確診患者的治療工作。受醫療保健系統成本壓力和家庭透析項目基礎設施擴張的推動，居家照護在終端用戶中成長速度最快。
“到2025年，北美將佔據全球血液透析和腹膜透析市場最大的佔有率，但預計亞太地區在預測期內將實現最高的複合年成長率。”
到2025年，北美將佔據全球血液透析和腹膜透析市場最大的佔有率。根據美國腎臟數據系統（USRDS）2023年度數據報告，美國將成為該地區的主要驅動力，這主要得益於終末期腎功能衰竭末期腎功能衰竭（ESRD）患者數量龐大且呈結構性成長，預計將超過80.8萬人。成熟的醫療保險ESRD預付制報銷框架將於2026年生效，屆時透析服務的固定基本費用為每次281.71美元，這將為產品供應商和服務提供者帶來穩定的收入前景。該地區還擁有密集的透析中心網路，約有7,600家獲得末期腎功能衰竭保險和醫療補助服務中心（CMS）認證的ESRD中心，並且是許多全球主要行業參與者的所在地。亞太地區是成長最快的區域市場。中國和印度是成長的主要驅動力，兩國政府支持的慢性腎臟病（CKD）全民健保計畫和透析補貼計畫加速了透析中心的病患登記人數。
全球血液透析和腹膜透析市場的一些領先公司包括費森尤斯醫療（德國）、Vantive（美國）、貝朗（德國）、尼普洛株式會社（日本）、日機裝（日本）、達維塔公司（美國）、旭化成醫療（日本）、東麗醫療（日本）、JMS（日本）、Outset Medical（美國）。
研究範圍：本研究報告涵蓋全球血液透析和腹膜透析市場，按產品和服務（血液透析市場和腹膜透析市場）、血液透析產品和服務（血液透析設備、血液透析耗材和設備以及血液透析服務）、血液透析設備類型（機構血液透析設備和家用血液透析設備）、血液透析耗材類型（透析器、血液迴路裝置和管路、血液透析濃縮液/透析液、血液透析通路產品及其他）、血液透析服務類型（機構血液透析服務和家用血液透析服務）以及腹膜透析產品和服務（腹膜濃縮液）進行細分。報告涵蓋一系列產品和服務，包括透析液、腹膜透析裝置、腹膜透析導管、腹膜透析輸液裝置、其他腹膜透析產品和腹膜透析服務；血液透析療法（常規長期血液透析、短期門診血液透析和夜間血液透析）。本報告詳細闡述了推動全球血液透析和腹膜透析市場成長的關鍵因素，包括：居家照護療法類型（持續性攜帶式腹膜透析 (CAPD) 和自動化腹膜透析 (APD)）；適應症（末期腎功能衰竭腎病 (ESRD)、急性腎損傷 (AKI) 及其他）；美國本土（醫院、獨立透析中心、美國家庭護理機構及其他）；
購買本報告的主要好處
- 關鍵促進因素、阻礙因素、機會和挑戰分析：深入了解影響全球血液透析和腹膜透析市場的關鍵因素，包括慢性腎臟病(CKD) 和末期腎功能衰竭(ESRD) 患病率上升、家庭透析的普及、有利的報銷政策、高昂的治療成本、某些市場對家庭血液透析 (HD) 報銷不足、與數字
- 市場趨勢：本報告提供 2024 年至 2031 年所有產品、服務、治療、疾病適應症、最終用戶和區域細分市場的當前和預測市場規模數據。除了以 2025 年為基準年的數據外，還包括 2024 年以來的完整歷史數據。
- 市場多元化：我們確定了高成長領域，例如 HD Access 產品、家庭血液透析服務、居家照護環境和亞太市場，並提供了 20 多個市場的具體國家細分數據。
- 競爭評估：我們評估了費森尤斯醫療、萬迪威、貝朗、尼普洛株式會社、日機裝、達維塔株式會社、旭化成醫療、東麗醫療、JMS、Outset Medical和羅克韋爾醫療等主要參與者的競爭地位，並分析了每家公司的產品系列、戰略和最新發展。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 任務
- 未滿足的需求和未開發的領域
- 相互關聯的市場與跨產業機遇
- 一級/二級/三級公司的策略性舉措
第5章 產業趨勢
- 波特五力分析
- 總體經濟指標
- 供應鏈分析
- 價值鏈分析
- 生態系分析
- 價格分析
- 貿易分析
- 退款方案
- 2026-2027 年主要會議和活動
- 影響客戶業務的趨勢/顛覆性因素
- 投資和資金籌措場景
- 案例研究分析
- 美國關稅對2025年血液透析及腹膜透析市場的影響
第6章：技術進步、人工智慧的影響、專利、創新與未來應用
- 技術分析
- 技術/產品藍圖
- 專利分析
- 未來應用
- 人工智慧/生成式人工智慧對血液透析和腹膜透析市場的影響
第7章：監理情勢與永續性舉措
- 監理情勢
- 法規結構
- 監管機構、政府機構和其他組織
- 業界標準
- 對永續性的承諾
- 減少醫療廢棄物，使用環保材料和包裝。
- 水、能源和資源效率
- 認證、標籤檢視和環境標準
第8章：顧客趨勢與購買行為
- 決策流程
- 採購過程中的關鍵相關人員及其標準
- 實施障礙和內部挑戰
- 各個終端用戶產業尚未滿足的需求
- 市場盈利
第9章：血液透析市場（依產品/服務分類）
- 血液透析服務
- 血液透析產品
- 血液透析市場（依治療方法分類）
- 血液透析水處理系統市場（按類型分類）
第10章：腹膜透析市場（依產品/服務分類）
- 腹膜透析產品
- 腹膜透析服務
- 腹膜透析市場（依治療方法分類）
第11章 血液透析和腹膜透析市場（按應用領域分類）
- 末期腎功能衰竭
- 急性腎損傷
- 其他
第12章 血液透析和腹膜透析市場（按最終用戶分類）
- 醫院
- 獨立透析中心
- 居家護理設施
- 其他
第13章 血液透析和腹膜透析市場（按地區分類）
- 北美洲
- 北美宏觀經濟展望
- 北美：血液透析和腹膜透析市場按類型分類的銷售分析（2024-2031 年）
- 美國
- 加拿大
- 歐洲
- 歐洲宏觀經濟展望
- 歐洲：血液透析和腹膜透析市場按類型分類的銷售分析（2024-2031 年）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 亞太地區宏觀經濟展望
- 亞太地區：血液透析和腹膜透析市場按類型分類的銷售分析（2024-2031 年）
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他
- 拉丁美洲
- 拉丁美洲宏觀經濟展望
- 拉丁美洲：血液透析和腹膜透析市場按類型分類的銷售分析（2024-2031 年）
- 巴西
- 墨西哥
- 其他
- 中東和非洲
- 中東與非洲：宏觀經濟展望
- 中東和非洲：血液透析和腹膜透析市場按類型分類的銷售分析（2024-2031 年）
- 海灣合作理事會國家
- 其他
第14章 競爭格局
- 概述
- 主要參與企業的競爭策略/優勢，2023年6月至2026年
- 收入分析
- 市佔率分析
- 品牌/產品對比
- 企業估值矩陣：主要公司，2025 年
- 公司估值矩陣：新創企業/中小企業，2025 年
- 企業估值和財務指標
- 競爭格局
第15章：公司簡介
- 主要參與企業
- FRESENIUS MEDICAL CARE AG
- DAVITA INC.
- VANTIVE
- US RENAL CARE, INC.
- B. BRAUN SE
- NIPRO CORPORATION
- DIAVERUM AB
- ASAHI KASEI MEDICAL CO., LTD.
- TORAY INDUSTRIES, INC.
- NIKKISO CO., LTD.
- MOZARC MEDICAL
- BD
- JMS CO., LTD.
- MERIT MEDICAL SYSTEMS
- TERUMO CORPORATION
- 其他公司
- ALLMED MEDICAL PRODUCTS CO., LTD.
- OUTSET MEDICAL, INC.
- ROCKWELL MEDICAL, INC.
- AMERIWATER LLC
- DIALIFE SA
- QUANTA DIALYSIS TECHNOLOGIES LTD
- ISOPURE CORP.
- POLY MEDICURE LIMITED
- ATLANTIC BIOMEDICAL
- AMECATH
第16章調查方法
第17章附錄
Product Code: MD 2157
The global hemodialysis and peritoneal dialysis market was valued at USD 102.7 billion in 2026 and is expected to reach USD 141.5 billion by 2031, growing at a CAGR of 6.6% during the forecast period. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), driven by increasing rates of diabetes, hypertension, and aging populations worldwide, is the primary force behind market expansion.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | By Product & Service, Machine Type, Consumables Type, Service Type, Modality , Disease Indication, End User |
| Regions covered | Europe, North America, Asia Pacific, Latin America, Middle East, and Africa |
Growing adoption of home-based dialysis therapies, supported by cost-containment policies in healthcare systems and payer reimbursement frameworks such as the Centers for Medicare & Medicaid Services (CMS) in the US, is broadening the patient base for both home hemodialysis and peritoneal dialysis. Expanding dialysis infrastructure in emerging markets across Asia Pacific, Latin America, and the Middle East and Africa is further adding to global patient volumes. High treatment costs and poor reimbursement for home hemodialysis in several markets outside North America remain constraints on faster adoption of home-based modalities.
"The HD access products subsegment is expected to register the highest CAGR among HD consumables during the forecast period."
Among the HD consumables and supplies segments, HD access products are projected to grow at the highest CAGR during the forecast period. Vascular access is a prerequisite for every hemodialysis session, and the structural demand it creates is consistent across care settings. Clinical guidelines from the National Kidney Foundation's KDOQI protocols, which prioritize arteriovenous fistula creation as the preferred access method, are driving procedure volumes and associated product consumption. The increasing use of tunneled hemodialysis catheters as a bridge to permanent access, the expanding patient population requiring long-term access management, and growing demand for single-use access needles and securement products are all contributing to this segment's growth. Dialyzers, the second-fastest-growing subsegment, are also benefiting from rising clinical adoption of high-flux and medium-cut-off membrane technologies that improve middle-molecule clearance relative to standard membranes.
"Hospitals accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025."
By end user, hospitals held the largest share of the global hemodialysis and peritoneal dialysis market in 2025. Hospital-based dialysis units manage the full clinical complexity of the ESRD and AKI patient population, including newly diagnosed patients, those with significant comorbidities, and critical care patients requiring continuous renal replacement therapy. The concentration of specialized nephrology staff, dialysis equipment, and emergency infrastructure within hospital settings makes them the default point of care for patients initiating treatment. Independent dialysis centers collectively represent the largest channel but are distributed across a fragmented operator landscape, while hospitals manage a disproportionate share of high-acuity and newly incident patients. Home care settings are growing at the fastest rate among end users, driven by cost pressures in the healthcare system and the expansion of home dialysis program infrastructure.
"North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025, while Asia Pacific is expected to register the highest CAGR during the forecast period."
North America accounted for the largest share of the global hemodialysis and peritoneal dialysis market in 2025. The US is the primary driver within this region, supported by a large and structurally growing ESRD patient population of more than 808,000 individuals, according to the United States Renal Data System 2023 Annual Data Report. A mature reimbursement framework under the Medicare ESRD Prospective Payment System, which covers dialysis services at a finalized base rate of USD 281.71 per treatment for calendar year 2026, provides consistent revenue visibility for both product suppliers and service operators. The region is also home to a concentrated network of dialysis facilities, with approximately 7,600 CMS-recognized ESRD centers and major global industry participants. Asia Pacific is the fastest-growing regional market. China and India are the primary growth engines, with government-backed universal CKD coverage programs and subsidized dialysis access schemes accelerating patient enrollment at dialysis centers in both countries.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the hemodialysis and peritoneal dialysis market.
- By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
- By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
Fresenius Medical Care (Germany), Vantive (US), B. Braun (Germany), Nipro Corporation (Japan), Nikkiso Co., Ltd. (Japan), DaVita Inc. (US), Asahi Kasei Medical Co., Ltd. (Japan), Toray Medical Co., Ltd. (Japan), JMS Co., Ltd. (Japan), Outset Medical (US), and Rockwell Medical (US) are some of the key players in the global hemodialysis and peritoneal dialysis market.
Study Coverage: This research report categorizes the global hemodialysis and peritoneal dialysis market by product and service (hemodialysis market and peritoneal dialysis market), HD product & service (HD machines, HD consumables & supplies, and HD services), HD machine type (center-use HD machines and home-use HD machines), HD consumables type (dialyzers, bloodlines sets & tubes, hemodialysis concentrates/dialysates, HD access products, and others), HD service type (in-center hemodialysis services and home hemodialysis (HHD) services), PD product & service (PD concentrates/dialysates, PD machines, PD catheters, PD transfer sets, other PD products, and PD services), HD modality (conventional long-term hemodialysis, short daily hemodialysis, and nocturnal hemodialysis), PD modality [continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)], disease indication (end-stage renal disease (ESRD), acute kidney injury (AKI), and others), end user (hospitals, independent dialysis centers, home care settings, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The report provides detailed information on the key factors driving growth in the global hemodialysis and peritoneal dialysis markets.
Key Benefits of Buying this Report
- Analysis of Key Drivers, Restraints, Opportunities, and Challenges: Gain insights into the principal factors shaping the global hemodialysis and peritoneal dialysis market, including rising CKD and ESRD prevalence, expanding home dialysis adoption, favorable reimbursement policies, high treatment costs, poor home HD reimbursement in select markets, digital health integration opportunities, and patient compliance challenges.
- Market Development: Understand current and projected market sizes across all product, service, modality, disease indication, end-user, and regional segments from 2024 to 2031, with base year data for 2025 and a complete historical series from 2024.
- Market Diversification: Identify high-growth pockets including HD access products, home hemodialysis services, home care settings, and the Asia Pacific regional market, along with country-level breakdowns for 20+ markets.
- Competitive Assessment: Evaluate the competitive positioning of key players including Fresenius Medical Care, Vantive, B. Braun, Nipro Corporation, Nikkiso Co., Ltd., DaVita Inc., Asahi Kasei Medical Co., Ltd., Toray Medical Co., Ltd., JMS Co., Ltd., Outset Medical, and Rockwell Medical, with analysis of their product portfolios, strategies, and recent commercial developments.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.4 INCLUSIONS AND EXCLUSIONS
- 1.4.1 YEARS CONSIDERED
- 1.4.2 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 LIMITATIONS
- 1.7 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET OVERVIEW
- 3.2 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER AND COUNTRY (2025)
- 3.3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COUNTRY/REGION
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising prevalence of chronic kidney disease and end-stage renal disease
- 4.2.1.2 Increasing aging population susceptible to kidney disorders
- 4.2.1.3 Growing prevalence of diabetes and hypertension
- 4.2.1.4 Continuous technological advancements in dialysis machines and consumables
- 4.2.2 RESTRAINTS
- 4.2.2.1 High cost of dialysis treatment and infrastructure
- 4.2.2.2 Frequent product recalls and quality compliance issues
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Expansion of dialysis centers and renal care infrastructure
- 4.2.3.2 Investments in healthcare infrastructure in emerging markets
- 4.2.4 CHALLENGES
- 4.2.4.1 Shortage of nephrologists and trained dialysis professionals
- 4.2.4.2 Risk of dialysis-related infections and complications
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
- 4.5.1 STRATEGIC MOVES IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
- 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
- 5.3 SUPPLY CHAIN ANALYSIS
- 5.4 VALUE CHAIN ANALYSIS
- 5.5 ECOSYSTEM ANALYSIS
- 5.5.1 MANUFACTURERS
- 5.5.2 END USERS
- 5.5.3 REGULATORY BODIES
- 5.6 PRICING ANALYSIS
- 5.7 TRADE ANALYSIS
- 5.7.1 IMPORT DATA (HS CODE 9018)
- 5.7.2 EXPORT DATA FOR (HS CODE 9018)
- 5.8 REIMBURSEMENT SCENARIO
- 5.9 KEY CONFERENCES AND EVENTS, 2026-2027
- 5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.11 INVESTMENT AND FUNDING SCENARIO
- 5.12 CASE STUDY ANALYSIS
- 5.13 IMPACT OF 2025 US TARIFF - HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
- 5.13.1 INTRODUCTION
- 5.13.2 KEY TARIFF RATES
- 5.13.3 PRICE IMPACT ANALYSIS
- 5.13.4 IMPACT ON COUNTRIES/REGIONS
- 5.13.5 IMPACT ON END-USE SEGMENTS
- 5.13.5.1 Hospitals
- 5.13.5.2 Independent dialysis centers
- 5.13.5.3 Home care settings
- 5.13.5.4 Other end users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.1.1.1 High-volume hemodiafiltration (HDF)
- 6.1.1.2 Intelligent home dialysis platforms
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
- 6.1.2.1 Remote patient management platforms
- 6.1.2.2 Advanced dialyzer membrane technology
- 6.1.3 ADJACENT TECHNOLOGIES
- 6.1.3.1 Portable & wearable artificial kidney technologies
- 6.1.1 KEY EMERGING TECHNOLOGIES
- 6.2 TECHNOLOGY/PRODUCT ROADMAP
- 6.2.1 NEAR TERM (2025-2027)
- 6.2.2 MID-TERM (2028-2030)
- 6.2.3 LONG TERM (2030+)
- 6.3 PATENT ANALYSIS
- 6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS
- 6.4 FUTURE APPLICATIONS
- 6.4.1 AI-ASSISTED TREATMENT PLANNING AND THERAPY OPTIMIZATION
- 6.4.2 PERSONALIZED DIALYSIS THERAPY
- 6.4.3 CONNECTED DIALYSIS WORKFLOWS AND DIGITAL INTEGRATION
- 6.5 IMPACT OF AI/GEN AI ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
- 6.5.1 INTRODUCTION
- 6.5.2 MARKET POTENTIAL OF AI IN HEMODIALYSIS AND PERITONEAL DIALYSIS
- 6.5.3 AI USE CASES
- 6.5.4 KEY COMPANIES IMPLEMENTING AI
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
- 7.1 REGULATORY LANDSCAPE
- 7.1.1 REGULATORY FRAMEWORK
- 7.1.1.1 North America
- 7.1.1.2 Europe
- 7.1.1.3 Asia Pacific
- 7.1.1.4 Latin America
- 7.1.1.5 Middle East & Africa
- 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.3 INDUSTRY STANDARDS
- 7.1.1 REGULATORY FRAMEWORK
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 REDUCING MEDICAL WASTE & USE OF LOWER-IMPACT MATERIALS AND PACKAGING
- 7.2.2 WATER, ENERGY, & RESOURCE EFFICIENCY
- 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
9 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE
- 9.1 INTRODUCTION
- 9.2 HEMODIALYSIS SERVICES
- 9.2.1 IN-CENTER HEMODIALYSIS SERVICES
- 9.2.1.1 Growing geriatric population and increasing government healthcare expenditure to drive segment
- 9.2.2 HOME HEMODIALYSIS SERVICES
- 9.2.2.1 Poor reimbursement scenario and high treatment costs to limit market growth
- 9.2.1 IN-CENTER HEMODIALYSIS SERVICES
- 9.3 HEMODIALYSIS PRODUCTS
- 9.3.1 HEMODIALYSIS MACHINES
- 9.3.1.1 Center-use hemodialysis machines
- 9.3.1.1.1 Rising number of renal care centers to aid segment growth
- 9.3.1.1.2 Volume analysis of center-use hemodialysis machines, 2024-2031 (ten thousand units)
- 9.3.1.2 Home-use hemodialysis machines
- 9.3.1.2.1 Lesser hospital stays and better clinical outcomes to propel segment growth
- 9.3.1.2.2 Volume analysis of home-use hemodialysis machines, 2024-2031 (ten thousand units)
- 9.3.1.1 Center-use hemodialysis machines
- 9.3.2 HEMODIALYSIS CONSUMABLES & SUPPLIES
- 9.3.2.1 Dialyzers
- 9.3.2.1.1 Dialyzers market, by material
- 9.3.2.1.1.1 Synthetic dialyzers
- 9.3.2.1.1.1.1 High physical strength and increased chemical resistance to drive segment
- 9.3.2.1.1.1.2 Volume analysis of synthetic dialyzers, 2024-2031 (Ten Thousand Units)
- 9.3.2.1.1.2 Cellulose-based dialyzers
- 9.3.2.1.1.2.1 Affordability and high biocompatibility to support segment growth
- 9.3.2.1.1.2.2 volume analysis of cellulose-based dialyzers, 2024-2031 (ten thousand units)
- 9.3.2.1.1.1 Synthetic dialyzers
- 9.3.2.1.2 Dialyzers market, by flux
- 9.3.2.1.2.1 High-flux dialyzers
- 9.3.2.1.2.1.1 High-flux dialyzers to command larger market share during forecast period
- 9.3.2.1.2.1.2 Volume analysis of high-flux dialyzers, 2024-2031 (Ten Thousand units)
- 9.3.2.1.2.2 Low-flux dialyzers
- 9.3.2.1.2.2.1 Ability to filter small toxin particles to propel segment growth
- 9.3.2.1.2.2.2 Volume analysis of low-flux dialyzers, 2024-2031 (Ten Thousand Units)
- 9.3.2.1.2.1 High-flux dialyzers
- 9.3.2.1.1 Dialyzers market, by material
- 9.3.2.2 Bloodline sets and tubes
- 9.3.2.2.1 High pricing and reduced rate of reuse to limit market expansion
- 9.3.2.2.2 Volume analysis of bloodline sets and tubes, 2024-2031 (Ten Thousand Units)
- 9.3.2.3 Concentrates/Dialysates
- 9.3.2.3.1 Alkaline concentrates
- 9.3.2.3.1.1 Growing consumption before dialysis to boost segment growth
- 9.3.2.3.1.2 Volume analysis of alkaline concentrates, 2024-2031 (Ten Thousand Units)
- 9.3.2.3.2 Acidic concentrates
- 9.3.2.3.2.1 Increased number of side effects to limit segment growth
- 9.3.2.3.2.2 Volume analysis of acidic concentrates, 2024-2031 (Ten Thousand Units)
- 9.3.2.3.1 Alkaline concentrates
- 9.3.2.4 Access products
- 9.3.2.4.1 AV fistula needles
- 9.3.2.4.1.1 Better blood flow and lower infection risk to aid segment growth
- 9.3.2.4.2 AV grafts
- 9.3.2.4.2.1 Increased number of patients requiring long-term dialysis to support segment growth
- 9.3.2.4.3 Central venous catheters
- 9.3.2.4.3.1 Increased use in temporary vascular access for short-term dialysis to boost segment growth
- 9.3.2.4.1 AV fistula needles
- 9.3.2.5 Other hemodialysis consumables & supplies
- 9.3.2.5.1 Volume analysis of other hemodialysis consumables, 2024-2031 (Ten Thousand Units)
- 9.3.2.1 Dialyzers
- 9.3.1 HEMODIALYSIS MACHINES
- 9.4 HEMODIALYSIS MARKET, BY MODALITY
- 9.4.1 CONVENTIONAL HEMODIALYSIS
- 9.4.1.1 Technological advancements and rising number of dialysis centers to drive segment
- 9.4.2 SHORT DAILY HEMODIALYSIS
- 9.4.2.1 Improved blood pressure control and better calcium-phosphorus balance to augment segment growth
- 9.4.3 NOCTURNAL HEMODIALYSIS
- 9.4.3.1 Lower procedure costs to aid segment growth
- 9.4.1 CONVENTIONAL HEMODIALYSIS
- 9.5 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE
- 9.5.1 CENTRAL WATER DISINFECTION SYSTEMS
- 9.5.1.1 Cost-effectiveness and easy maintenance to drive market
- 9.5.1.1.1 Volume analysis of central water disinfection systems, 2024-2031 (Ten Thousand Units)
- 9.5.1.1 Cost-effectiveness and easy maintenance to drive market
- 9.5.2 PORTABLE WATER DISINFECTION SYSTEMS
- 9.5.2.1 User-friendly operations and improved microbiological purity to support segment growth
- 9.5.2.1.1 Volume analysis of portable water disinfection systems, 2024-2031 (Ten Thousand Units)
- 9.5.2.1 User-friendly operations and improved microbiological purity to support segment growth
- 9.5.1 CENTRAL WATER DISINFECTION SYSTEMS
10 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE
- 10.1 INTRODUCTION
- 10.2 PERITONEAL DIALYSIS PRODUCTS
- 10.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
- 10.2.1.1 High demand for concentrates to boost segment growth
- 10.2.1.1.1 Volume analysis of peritoneal dialysis concentrates/ dialysates, 2024-2031 (Ten Thousand Units)
- 10.2.1.1 High demand for concentrates to boost segment growth
- 10.2.2 PERITONEAL DIALYSIS MACHINES
- 10.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption
- 10.2.2.1.1 Volume analysis of peritoneal dialysis machines, 2024-2031 (Ten Thousand Units)
- 10.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption
- 10.2.3 PERITONEAL DIALYSIS CATHETERS
- 10.2.3.1 Favorable reimbursement policies to support market growth
- 10.2.3.1.1 Volume analysis of peritoneal dialysis catheters, 2024-2031 (Ten Thousand Units)
- 10.2.3.1 Favorable reimbursement policies to support market growth
- 10.2.4 PERITONEAL DIALYSIS TRANSFER SETS
- 10.2.4.1 Increasing number of patients in emerging economies to aid market growth
- 10.2.4.1.1 Volume analysis of peritoneal dialysis transfer sets, 2024-2031 (Ten Thousand Units)
- 10.2.4.1 Increasing number of patients in emerging economies to aid market growth
- 10.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS
- 10.2.5.1 Volume analysis of other peritoneal dialysis products, 2024-2031 (Ten Thousand Units)
- 10.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
- 10.3 PERITONEAL DIALYSIS SERVICES
- 10.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET
- 10.4 PERITONEAL DIALYSIS MARKET, BY MODALITY
- 10.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
- 10.4.1.1 Superior clearance of high-molecular-weight substances to drive market
- 10.4.2 AUTOMATED PERITONEAL DIALYSIS
- 10.4.2.1 Risk of rapid decline in residual renal functions to limit adoption
- 10.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS
11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION
- 11.1 INTRODUCTION
- 11.2 END-STAGE RENAL DISEASE
- 11.2.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
- 11.3 ACUTE KIDNEY INJURY
- 11.3.1 INCREASING NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH
- 11.4 OTHER INDICATIONS
12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER
- 12.1 INTRODUCTION
- 12.2 HOSPITALS
- 12.2.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET
- 12.3 INDEPENDENT DIALYSIS CENTERS
- 12.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH
- 12.4 HOME CARE SETTINGS
- 12.4.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH
- 12.5 OTHER END USERS
13 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION
- 13.1 INTRODUCTION
- 13.2 NORTH AMERICA
- 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 13.2.2 NORTH AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031
- 13.2.3 US
- 13.2.3.1 US to dominate North American market during study period
- 13.2.4 CANADA
- 13.2.4.1 Shortage of dialysis facilities and increased treatment cost to restrain market expansion
- 13.3 EUROPE
- 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 13.3.2 EUROPE: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031
- 13.3.3 GERMANY
- 13.3.3.1 Rising number of end-stage renal disease patients to boost market growth
- 13.3.4 UK
- 13.3.4.1 Expanding home dialysis programs and strong NHS support to drive market
- 13.3.5 FRANCE
- 13.3.5.1 Strong reimbursement framework and growing home dialysis adoption to fuel market
- 13.3.6 ITALY
- 13.3.6.1 Universal healthcare coverage and rising CKD burden to support market growth
- 13.3.7 SPAIN
- 13.3.7.1 Increasing CKD prevalence and expanding renal care infrastructure to drive market
- 13.3.8 REST OF EUROPE
- 13.4 ASIA PACIFIC
- 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031
- 13.4.3 CHINA
- 13.4.3.1 Expanding dialysis infrastructure and large CKD patient base to drive market
- 13.4.4 JAPAN
- 13.4.4.1 Advanced dialysis infrastructure and universal reimbursement to support market growth
- 13.4.5 INDIA
- 13.4.5.1 Government-led dialysis expansion and rising CKD burden to fuel market
- 13.4.6 AUSTRALIA
- 13.4.6.1 High adoption of home dialysis and strong healthcare system to support market growth
- 13.4.7 SOUTH KOREA
- 13.4.7.1 Growing CKD burden and expanding renal care services to drive market
- 13.4.8 REST OF ASIA PACIFIC
- 13.5 LATIN AMERICA
- 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 13.5.2 LATIN AMERICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031
- 13.5.3 BRAZIL
- 13.5.3.1 Large dialysis patient base and expanding renal care infrastructure to drive market
- 13.5.4 MEXICO
- 13.5.4.1 Healthcare reforms and expanding access to dialysis to support market growth
- 13.5.5 REST OF LATIN AMERICA
- 13.6 MIDDLE EAST & AFRICA
- 13.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
- 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031
- 13.6.3 GCC COUNTRIES
- 13.6.3.1 Kingdom of Saudi Arabia (KSA)
- 13.6.3.1.1 Saudi Vision 2030 and expanding dialysis infrastructure to drive market
- 13.6.3.2 United Arab Emirates (UAE)
- 13.6.3.2.1 Growing investments in renal care and rising CKD burden to support market growth
- 13.6.3.3 Other GCC countries
- 13.6.3.1 Kingdom of Saudi Arabia (KSA)
- 13.6.4 REST OF MIDDLE EAST & AFRICA
14 COMPETITIVE LANDSCAPE
- 14.1 OVERVIEW
- 14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023-JUNE 2026
- 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
- 14.3 REVENUE ANALYSIS
- 14.4 MARKET SHARE ANALYSIS
- 14.4.1 GLOBAL HEMODIALYSIS MARKET SHARE ANALYSIS, 2025
- 14.4.1.1 US hemodialysis market share analysis, 2025
- 14.4.1.2 Europe hemodialysis market share analysis, 2025
- 14.4.2 GLOBAL PERITONEAL DIALYSIS MARKET SHARE ANALYSIS, 2025
- 14.4.2.1 US peritoneal dialysis market share analysis, 2025
- 14.4.2.2 Europe peritoneal dialysis market share analysis, 2025
- 14.4.1 GLOBAL HEMODIALYSIS MARKET SHARE ANALYSIS, 2025
- 14.5 BRAND/PRODUCT COMPARISON
- 14.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 14.6.1 STARS
- 14.6.2 EMERGING LEADERS
- 14.6.3 PERVASIVE PLAYERS
- 14.6.4 PARTICIPANTS
- 14.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 14.6.5.1 Company footprint
- 14.6.5.2 Region footprint
- 14.6.5.3 Hemodialysis product & service footprint
- 14.6.5.4 Hemodialysis modality footprint
- 14.6.5.5 Hemodialysis water treatment system type footprint
- 14.6.5.6 Peritoneal dialysis product & service footprint
- 14.6.5.7 Peritoneal dialysis modality footprint
- 14.6.5.8 Hemodialysis and peritoneal dialysis application footprint
- 14.6.5.9 Hemodialysis and peritoneal dialysis end user footprint
- 14.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 14.7.1 PROGRESSIVE COMPANIES
- 14.7.2 RESPONSIVE COMPANIES
- 14.7.3 DYNAMIC COMPANIES
- 14.7.4 STARTING BLOCKS
- 14.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 14.7.5.1 Detailed list of key startups/SMEs
- 14.7.5.2 Competitive benchmarking of key startups/SMEs
- 14.8 COMPANY VALUATION AND FINANCIAL METRICS
- 14.8.1 COMPANY VALUATION
- 14.8.2 FINANCIAL METRICS
- 14.9 COMPETITIVE SCENARIO
- 14.9.1 PRODUCT LAUNCHES & APPROVALS
- 14.9.2 DEALS
- 14.9.3 EXPANSIONS
- 14.9.4 OTHER DEVELOPMENTS
15 COMPANY PROFILES
- 15.1 KEY PLAYERS
- 15.1.1 FRESENIUS MEDICAL CARE AG
- 15.1.1.1 Business overview
- 15.1.1.2 Products/Solutions/Services offered
- 15.1.1.3 Recent developments
- 15.1.1.3.1 Product launches & approvals
- 15.1.1.3.2 Deals
- 15.1.1.3.3 Expansions
- 15.1.1.3.4 Other developments
- 15.1.1.4 MnM view
- 15.1.1.4.1 Key strengths
- 15.1.1.4.2 Strategic choices
- 15.1.1.4.3 Weaknesses & competitive threats
- 15.1.2 DAVITA INC.
- 15.1.2.1 Business overview
- 15.1.2.2 Products/Solutions/Services offered
- 15.1.2.3 Recent developments
- 15.1.2.3.1 Deals
- 15.1.2.4 MnM view
- 15.1.2.4.1 Key strengths
- 15.1.2.4.2 Strategic choices
- 15.1.2.4.3 Weaknesses & competitive threats
- 15.1.3 VANTIVE
- 15.1.3.1 Business overview
- 15.1.3.2 Products/Solutions/Services offered
- 15.1.3.3 Recent developments
- 15.1.3.3.1 Product launches & approvals
- 15.1.3.3.2 Deals
- 15.1.3.3.3 Expansions
- 15.1.3.3.4 Other developments
- 15.1.3.4 MnM view
- 15.1.3.4.1 Key strengths
- 15.1.3.4.2 Strategic choices
- 15.1.3.4.3 Weaknesses & competitive threats
- 15.1.4 U.S. RENAL CARE, INC.
- 15.1.4.1 Business overview
- 15.1.4.2 Products/Solutions/Services offered
- 15.1.4.3 MnM view
- 15.1.4.3.1 Key strengths
- 15.1.4.3.2 Strategic choices
- 15.1.4.3.3 Weaknesses & competitive threats
- 15.1.5 B. BRAUN SE
- 15.1.5.1 Business overview
- 15.1.5.2 Products/Solutions/Services offered
- 15.1.5.3 Recent developments
- 15.1.5.3.1 Expansions
- 15.1.5.4 MnM view
- 15.1.5.4.1 Key strengths
- 15.1.5.4.2 Strategic choices
- 15.1.5.4.3 Weaknesses & competitive threats
- 15.1.6 NIPRO CORPORATION
- 15.1.6.1 Business overview
- 15.1.6.2 Products/Solutions/Services offered
- 15.1.6.3 Recent developments
- 15.1.6.3.1 Product launches & approvals
- 15.1.6.3.2 Deals
- 15.1.6.3.3 Expansions
- 15.1.7 DIAVERUM AB
- 15.1.7.1 Business overview
- 15.1.7.2 Products/Solutions/Services offered
- 15.1.7.3 Recent developments
- 15.1.7.3.1 Deals
- 15.1.7.3.2 Expansions
- 15.1.8 ASAHI KASEI MEDICAL CO., LTD.
- 15.1.8.1 Business overview
- 15.1.8.2 Products/Solutions/Services offered
- 15.1.8.3 Recent developments
- 15.1.8.3.1 Deals
- 15.1.8.3.2 Other developments
- 15.1.9 TORAY INDUSTRIES, INC.
- 15.1.9.1 Business overview
- 15.1.9.2 Products/Solutions/Services offered
- 15.1.10 NIKKISO CO., LTD.
- 15.1.10.1 Business overview
- 15.1.10.2 Products/Solutions/Services offered
- 15.1.10.3 Recent developments
- 15.1.10.3.1 Product launches & approvals
- 15.1.10.3.2 Deals
- 15.1.11 MOZARC MEDICAL
- 15.1.11.1 Business overview
- 15.1.11.2 Products/Solutions/Services offered
- 15.1.11.3 Recent developments
- 15.1.11.3.1 Deals
- 15.1.12 BD
- 15.1.12.1 Business overview
- 15.1.12.2 Products/Solutions/Services offered
- 15.1.12.3 Recent developments
- 15.1.12.3.1 Deals
- 15.1.12.3.2 Expansions
- 15.1.13 JMS CO., LTD.
- 15.1.13.1 Business overview
- 15.1.13.2 Products/Solutions/Services offered
- 15.1.14 MERIT MEDICAL SYSTEMS
- 15.1.14.1 Business overview
- 15.1.14.2 Products/Solutions/Services offered
- 15.1.14.3 Recent developments
- 15.1.14.3.1 Deals
- 15.1.15 TERUMO CORPORATION
- 15.1.15.1 Business overview
- 15.1.15.2 Products/Solutions/Services offered
- 15.1.1 FRESENIUS MEDICAL CARE AG
- 15.2 OTHER PLAYERS
- 15.2.1 ALLMED MEDICAL PRODUCTS CO., LTD.
- 15.2.2 OUTSET MEDICAL, INC.
- 15.2.3 ROCKWELL MEDICAL, INC.
- 15.2.4 AMERIWATER LLC
- 15.2.5 DIALIFE SA
- 15.2.6 QUANTA DIALYSIS TECHNOLOGIES LTD
- 15.2.7 ISOPURE CORP.
- 15.2.8 POLY MEDICURE LIMITED
- 15.2.9 ATLANTIC BIOMEDICAL
- 15.2.10 AMECATH
16 RESEARCH METHODOLOGY
- 16.1 RESEARCH DATA
- 16.1.1 SECONDARY DATA
- 16.1.1.1 Key secondary sources
- 16.1.2 PRIMARY DATA
- 16.1.2.1 Primary sources
- 16.1.2.2 Key data from primary sources
- 16.1.2.3 Key industry insights
- 16.1.2.4 Breakdown of primaries
- 16.1.1 SECONDARY DATA
- 16.2 MARKET SIZE ESTIMATION
- 16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
- 16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
- 16.2.3 APPROACH 3: TOP-DOWN APPROACH
- 16.2.4 APPROACH 4: BOTTOM-UP APPROACH
- 16.2.5 APPROACH 4: PRIMARY INTERVIEWS
- 16.2.6 APPROACH 5: DEMAND-SIDE APPROACH
- 16.2.7 APPROACH 6: VOLUME DATA ANALYSIS
- 16.3 DATA TRIANGULATION AND MARKET BREAKDOWN
- 16.4 MARKET SHARE ASSESSMENT
- 16.5 RESEARCH ASSUMPTIONS
- 16.5.1 STUDY ASSUMPTIONS
- 16.5.2 GROWTH RATE ASSUMPTIONS
- 16.6 RISK ASSESSMENT
- 16.7 RESEARCH LIMITATIONS
17 APPENDIX
- 17.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 17.2 CUSTOMIZATION OPTIONS
- 17.2.1 PRODUCT ANALYSIS
- 17.2.2 COMPANY INFORMATION
- 17.2.3 GEOGRAPHIC ANALYSIS
- 17.3 RELATED REPORTS
- 17.4 AUTHOR DETAILS
List of Tables
- TABLE 1 STANDARD CURRENCY CONVERSION RATES
- TABLE 2 AGE DISTRIBUTION OF KIDNEY CARE PATIENTS IN BRITISH COLUMBIA, BY TREATMENT MODALITY
- TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
- TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (USD BILLION)
- TABLE 5 LIST OF KEY HEMODIALYSIS AND PERITONEAL DIALYSIS MANUFACTURERS
- TABLE 6 LIST OF KEY END USERS
- TABLE 7 LIST OF KEY REGULATORY BODIES
- TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2023-2025 (USD)
- TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025 (USD)
- TABLE 10 IMPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 11 EXPORT DATA FOR HS CODE 9018-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 12 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
- TABLE 13 HOME PERITONEAL DIALYSIS WITH REMOTE PATIENT MONITORING
- TABLE 14 HOME HEMODIALYSIS SUPPORTING FULL-TIME EMPLOYMENT
- TABLE 15 HOME PERITONEAL DIALYSIS FOR VISUALLY IMPAIRED PATIENT
- TABLE 16 RECIPROCAL TARIFF RATES ADJUSTED BY US, 2025
- TABLE 17 KEY PRODUCT-RELATED TARIFFS
- TABLE 18 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA
- TABLE 19 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA
- TABLE 20 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK
- TABLE 21 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO
- TABLE 22 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PATENTS, 2023-2025
- TABLE 23 COMPANIES IMPLEMENTING AI
- TABLE 24 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 25 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 26 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 27 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 28 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
- TABLE 30 KEY BUYING CRITERIA FOR END USERS
- TABLE 31 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: ADOPTION BARRIERS AND INTERNAL CHALLENGES
- TABLE 32 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- TABLE 33 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: KEY PROFITABILITY DRIVERS
- TABLE 34 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 35 HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 36 HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 37 KEY PLAYERS PROVIDING IN-CENTER HEMODIALYSIS SERVICES
- TABLE 38 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 39 KEY PLAYERS PROVIDING HOME HEMODIALYSIS SERVICES
- TABLE 40 HOME HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 41 HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 42 HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 43 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 44 HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 45 KEY PLAYERS PROVIDING CENTER-USE HEMODIALYSIS MACHINES
- TABLE 46 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 47 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 48 KEY PLAYERS PROVIDING HOME-USE HEMODIALYSIS MACHINES
- TABLE 49 HOME-USE HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 50 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 51 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 52 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 53 DIALYZERS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 54 DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 55 KEY PLAYERS PROVIDING SYNTHETIC DIALYZERS
- TABLE 56 SYNTHETIC DIALYZERS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 57 SYNTHETIC DIALYZERS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 58 KEY PLAYERS PROVIDING CELLULOSE-BASED DIALYZERS
- TABLE 59 CELLULOSE-BASED DIALYZERS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 60 CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 61 DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 62 KEY PLAYERS PROVIDING HIGH-FLUX DIALYZERS
- TABLE 63 HIGH-FLUX DIALYZERS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 64 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 65 KEY PLAYERS PROVIDING LOW-FLUX DIALYZERS
- TABLE 66 LOW-FLUX DIALYZERS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 67 LOW-FLUX DIALYZERS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 68 KEY PLAYERS PROVIDING BLOODLINE SETS AND TUBES
- TABLE 69 BLOODLINE SETS AND TUBES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 70 BLOODLINE SETS AND TUBES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 71 CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 72 CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 73 KEY PLAYERS PROVIDING ALKALINE CONCENTRATES
- TABLE 74 ALKALINE CONCENTRATES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 75 ALKALINE CONCENTRATES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 76 KEY PLAYERS PROVIDING ACIDIC CONCENTRATES
- TABLE 77 ACIDIC CONCENTRATES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 78 ACIDIC CONCENTRATES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 79 ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 80 ACCESS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 81 KEY PLAYERS PROVIDING AV FISTULA NEEDLES
- TABLE 82 AV FISTULA NEEDLES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 83 KEY PLAYERS PROVIDING AV GRAFTS
- TABLE 84 AV GRAFTS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 85 KEY PLAYERS PROVIDING CENTRAL VENOUS CATHETERS
- TABLE 86 CENTRAL VENOUS CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 87 KEY PLAYERS PROVIDING OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES
- TABLE 88 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 89 OTHER HEMODIALYSIS CONSUMABLES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 90 HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 91 HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 92 HEMODIALYSIS MARKET FOR SHORT DAILY HEMODIALYSIS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 93 HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 94 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 95 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 96 KEY PLAYERS PROVIDING CENTRAL WATER DISINFECTION SYSTEMS
- TABLE 97 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 98 CENTRAL WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 99 KEY PLAYERS PROVIDING PORTABLE WATER DISINFECTION SYSTEMS
- TABLE 100 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 101 PORTABLE WATER DISINFECTION SYSTEMS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 102 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 103 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 104 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 105 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES
- TABLE 106 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 107 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 108 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS MACHINES
- TABLE 109 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 110 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 111 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS CATHETERS
- TABLE 112 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 113 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 114 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS TRANSFER SETS
- TABLE 115 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 116 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 117 KEY PLAYERS PROVIDING OTHER PERITONEAL DIALYSIS PRODUCTS
- TABLE 118 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 119 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 120 KEY PLAYERS PROVIDING PERITONEAL DIALYSIS SERVICES
- TABLE 121 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SERVICES, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 122 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 123 PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 124 PERITONEAL DIALYSIS MARKET FOR AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 125 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 126 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 127 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 128 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 129 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 130 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 131 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR INDEPENDENT DIALYSIS CENTERS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 132 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 133 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 134 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2024-2031 (USD BILLION)
- TABLE 135 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 136 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 137 NORTH AMERICA: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 138 NORTH AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 139 NORTH AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 140 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 141 NORTH AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 142 NORTH AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 143 NORTH AMERICA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 144 NORTH AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 145 NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 146 NORTH AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 147 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 148 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 149 NORTH AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 150 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 151 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 152 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 153 US: MACROECONOMIC INDICATORS
- TABLE 154 US: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 155 US: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 156 US: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 157 US: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 158 US: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 159 US: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 160 US: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 161 US: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 162 US: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 163 US: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 164 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 165 US: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 166 US: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 167 US: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 168 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 169 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 170 CANADA: MACROECONOMIC INDICATORS
- TABLE 171 CANADA: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 172 CANADA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 173 CANADA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 174 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 175 CANADA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 176 CANADA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 177 CANADA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 178 CANADA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 179 CANADA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 180 CANADA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 181 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 182 CANADA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 183 CANADA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 184 CANADA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 185 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 186 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 187 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 188 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 189 EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 190 EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 191 EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 192 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 193 EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 194 EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 195 EUROPE: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 196 EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 197 EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 198 EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 199 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 200 EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 201 EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 202 EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 203 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 204 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 205 GERMANY: MACROECONOMIC INDICATORS
- TABLE 206 GERMANY: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 207 GERMANY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 208 GERMANY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 209 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 210 GERMANY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 211 GERMANY: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 212 GERMANY: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 213 GERMANY: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 214 GERMANY: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 215 GERMANY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 216 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 217 GERMANY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 218 GERMANY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 219 GERMANY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 220 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 221 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 222 UK: MACROECONOMIC INDICATORS
- TABLE 223 UK: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 224 UK: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 225 UK: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 226 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 227 UK: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 228 UK: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 229 UK: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 230 UK: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 231 UK: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 232 UK: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 233 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 234 UK: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 235 UK: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 236 UK: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 237 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 238 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 239 FRANCE: MACROECONOMIC INDICATORS
- TABLE 240 FRANCE: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 241 FRANCE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 242 FRANCE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 243 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 244 FRANCE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 245 FRANCE: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 246 FRANCE: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 247 FRANCE: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 248 FRANCE: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 249 FRANCE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 250 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 251 FRANCE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 252 FRANCE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 253 FRANCE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 254 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 255 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 256 ITALY: MACROECONOMIC INDICATORS
- TABLE 257 ITALY: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 258 ITALY: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 259 ITALY: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 260 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 261 ITALY: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 262 ITALY: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 263 ITALY: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 264 ITALY: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 265 ITALY: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 266 ITALY: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 267 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 268 ITALY: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 269 ITALY: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 270 ITALY: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 271 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 272 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 273 SPAIN: MACROECONOMIC INDICATORS
- TABLE 274 SPAIN: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 275 SPAIN: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 276 SPAIN: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 277 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 278 SPAIN: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 279 SPAIN: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 280 SPAIN: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 281 SPAIN: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 282 SPAIN: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 283 SPAIN: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 284 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 285 SPAIN: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 286 SPAIN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 287 SPAIN: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 288 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 289 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 290 REST OF EUROPE: HEMODIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 291 REST OF EUROPE: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 292 REST OF EUROPE: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 293 REST OF EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 294 REST OF EUROPE: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 295 REST OF EUROPE: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 296 REST OF EUROPE: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 297 REST OF EUROPE: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 298 REST OF EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 299 REST OF EUROPE: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 300 REST OF EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 301 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 302 REST OF EUROPE: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 303 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 304 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 305 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 306 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 307 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 308 ASIA PACIFIC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 309 ASIA PACIFIC: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 310 ASIA PACIFIC: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 311 ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 312 ASIA PACIFIC: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 313 ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 314 ASIA PACIFIC: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 315 ASIA PACIFIC: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 316 ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 317 ASIA PACIFIC: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 318 ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 319 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 320 ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 321 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 322 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 323 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 324 CHINA: MACROECONOMIC INDICATORS
- TABLE 325 CHINA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 326 CHINA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 327 CHINA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 328 CHINA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 329 CHINA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 330 CHINA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 331 CHINA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 332 CHINA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 333 CHINA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 334 CHINA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 335 CHINA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 336 CHINA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 337 CHINA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 338 CHINA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 339 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 340 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 341 JAPAN: MACROECONOMIC INDICATORS
- TABLE 342 JAPAN: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 343 JAPAN: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 344 JAPAN: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 345 JAPAN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 346 JAPAN: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 347 JAPAN: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 348 JAPAN: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 349 JAPAN: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 350 JAPAN: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 351 JAPAN: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 352 JAPAN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 353 JAPAN: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 354 JAPAN: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 355 JAPAN: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 356 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 357 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 358 INDIA: MACROECONOMIC INDICATORS
- TABLE 359 INDIA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 360 INDIA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 361 INDIA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 362 INDIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 363 INDIA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 364 INDIA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 365 INDIA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 366 INDIA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 367 INDIA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 368 INDIA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 369 INDIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 370 INDIA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 371 INDIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 372 INDIA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 373 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 374 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 375 AUSTRALIA: MACROECONOMIC INDICATORS
- TABLE 376 AUSTRALIA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 377 AUSTRALIA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 378 AUSTRALIA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 379 AUSTRALIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 380 AUSTRALIA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 381 AUSTRALIA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 382 AUSTRALIA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 383 AUSTRALIA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 384 AUSTRALIA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 385 AUSTRALIA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 386 AUSTRALIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 387 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 388 AUSTRALIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 389 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 390 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 391 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 392 SOUTH KOREA: MACROECONOMIC INDICATORS
- TABLE 393 SOUTH KOREA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 394 SOUTH KOREA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 395 SOUTH KOREA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 396 SOUTH KOREA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 397 SOUTH KOREA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 398 SOUTH KOREA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 399 SOUTH KOREA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 400 SOUTH KOREA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 401 SOUTH KOREA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 402 SOUTH KOREA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 403 SOUTH KOREA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 404 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 405 SOUTH KOREA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 406 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 407 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 408 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 409 REST OF ASIA PACIFIC: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 410 REST OF ASIA PACIFIC: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 411 REST OF ASIA PACIFIC: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 412 REST OF ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 413 REST OF ASIA PACIFIC: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 414 REST OF ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 415 REST OF ASIA PACIFIC: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 416 REST OF ASIA PACIFIC: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 417 REST OF ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 418 REST OF ASIA PACIFIC: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 419 REST OF ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 420 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 421 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 422 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 423 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 424 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 425 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 426 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 427 LATIN AMERICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 428 LATIN AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 429 LATIN AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 430 LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 431 LATIN AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 432 LATIN AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 433 LATIN AMERICA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 434 LATIN AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 435 LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 436 LATIN AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 437 LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 438 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 439 LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 440 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 441 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 442 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 443 BRAZIL: MACROECONOMIC INDICATORS
- TABLE 444 BRAZIL: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 445 BRAZIL: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 446 BRAZIL: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 447 BRAZIL: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 448 BRAZIL: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 449 BRAZIL: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 450 BRAZIL: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 451 BRAZIL: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 452 BRAZIL: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 453 BRAZIL: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 454 BRAZIL: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 455 BRAZIL: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 456 BRAZIL: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 457 BRAZIL: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 458 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 459 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 460 MEXICO: MACROECONOMIC INDICATORS
- TABLE 461 MEXICO: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 462 MEXICO: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 463 MEXICO: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 464 MEXICO: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 465 MEXICO: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 466 MEXICO: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 467 MEXICO: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 468 MEXICO: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 469 MEXICO: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 470 MEXICO: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 471 MEXICO: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 472 MEXICO: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 473 MEXICO: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 474 MEXICO: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 475 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 476 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 477 REST OF LATIN AMERICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 478 REST OF LATIN AMERICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 479 REST OF LATIN AMERICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 480 REST OF LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 481 REST OF LATIN AMERICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 482 REST OF LATIN AMERICA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 483 REST OF LATIN AMERICA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 484 REST OF LATIN AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 485 REST OF LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 486 REST OF LATIN AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 487 REST OF LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 488 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 489 REST OF LATIN AMERICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 490 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 491 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 492 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 493 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (TEN THOUSAND UNITS)
- TABLE 494 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 495 MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 496 MIDDLE EAST & AFRICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 497 MIDDLE EAST & AFRICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 498 MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 499 MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 500 MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 501 MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 502 MIDDLE EAST & AFRICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 503 MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 504 MIDDLE EAST & AFRICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 505 MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 506 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 507 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 508 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 509 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 510 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 511 GCC COUNTRIES: HEMODIALYSIS MARKET, BY COUNTRY, 2024-2031 (USD BILLION)
- TABLE 512 GCC COUNTRIES: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 513 GCC COUNTRIES: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 514 GCC COUNTRIES: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 515 GCC COUNTRIES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 516 GCC COUNTRIES: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 517 GCC COUNTRIES: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 518 GCC COUNTRIES: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 519 GCC COUNTRIES: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 520 GCC COUNTRIES: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 521 GCC COUNTRIES: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 522 GCC COUNTRIES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 523 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 524 GCC COUNTRIES: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 525 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 526 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 527 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 528 KINGDOM OF SAUDI ARABIA: KEY MACRO INDICATORS
- TABLE 529 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 530 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 531 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 532 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 533 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 534 KINGDOM OF SAUDI ARABIA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 535 KINGDOM OF SAUDI ARABIA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 536 KINGDOM OF SAUDI ARABIA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 537 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 538 KINGDOM OF SAUDI ARABIA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 539 KINGDOM OF SAUDI ARABIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 540 KINGDOM OF SAUDI ARABIA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 541 KINGDOM OF SAUDI ARABIA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 542 KINGDOM OF SAUDI ARABIA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 543 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 544 KINGDOM OF SAUDI ARABIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 545 UNITED ARAB EMIRATES: KEY MACRO INDICATORS
- TABLE 546 UNITED ARAB EMIRATES: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 547 UNITED ARAB EMIRATES: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 548 UNITED ARAB EMIRATES: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 549 UNITED ARAB EMIRATES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 550 UNITED ARAB EMIRATES: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 551 UNITED ARAB EMIRATES: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 552 UNITED ARAB EMIRATES: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 553 UNITED ARAB EMIRATES: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 554 UNITED ARAB EMIRATES: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 555 UNITED ARAB EMIRATES: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 556 UNITED ARAB EMIRATES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 557 UNITED ARAB EMIRATES: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 558 UNITED ARAB EMIRATES: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 559 UNITED ARAB EMIRATES: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 560 UNITED ARAB EMIRATES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 561 UNITED ARAB EMIRATES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 562 OTHER GCC COUNTRIES: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 563 OTHER GCC COUNTRIES: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 564 OTHER GCC COUNTRIES: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 565 OTHER GCC COUNTRIES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 566 OTHER GCC COUNTRIES: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 567 OTHER GCC COUNTRIES: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 568 OTHER GCC COUNTRIES: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 569 OTHER GCC COUNTRIES: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 570 OTHER GCC COUNTRIES: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 571 OTHER GCC COUNTRIES: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 572 OTHER GCC COUNTRIES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 573 OTHER GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 574 OTHER GCC COUNTRIES: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 575 OTHER GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 576 OTHER GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 577 OTHER GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 578 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 579 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 580 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 581 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 582 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES AND SUPPLIES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 583 REST OF MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY MATERIAL, 2024-2031 (USD BILLION)
- TABLE 584 REST OF MIDDLE EAST & AFRICA: DIALYZERS MARKET, BY FLUX, 2024-2031 (USD BILLION)
- TABLE 585 REST OF MIDDLE EAST & AFRICA: ACCESS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 586 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2024-2031 (USD BILLION)
- TABLE 587 REST OF MIDDLE EAST & AFRICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 588 REST OF MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 589 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024-2031 (USD BILLION)
- TABLE 590 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 591 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY TYPE, 2024-2031 (USD BILLION)
- TABLE 592 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY APPLICATION, 2024-2031 (USD BILLION)
- TABLE 593 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024-2031 (USD BILLION)
- TABLE 594 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MARKET PLAYERS, 2023-JUNE 2026
- TABLE 595 GLOBAL HEMODIALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 596 US HEMODIALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 597 EUROPE HEMODIALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 598 GLOBAL PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 599 US PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 600 EUROPE PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 601 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGION FOOTPRINT
- TABLE 602 HEMODIALYSIS MARKET: HEMODIALYSIS PRODUCT & SERVICE FOOTPRINT
- TABLE 603 HEMODIALYSIS MARKET: MODALITY FOOTPRINT
- TABLE 604 HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET: TYPE FOOTPRINT
- TABLE 605 PERITONEAL DIALYSIS MARKET: PRODUCT & SERVICE FOOTPRINT
- TABLE 606 PERITONEAL DIALYSIS MARKET: MODALITY FOOTPRINT
- TABLE 607 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: APPLICATION FOOTPRINT
- TABLE 608 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: END USER FOOTPRINT
- TABLE 609 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 610 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
- TABLE 611 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, 2023-JUNE 2026
- TABLE 612 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEALS, 2023-JUNE 2026
- TABLE 613 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: EXPANSIONS, 2023-JUNE 2026
- TABLE 614 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OTHER DEVELOPMENTS, 2023-JUNE 2026
- TABLE 615 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
- TABLE 616 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 617 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES & APPROVALS
- TABLE 618 FRESENIUS MEDICAL CARE AG: DEALS
- TABLE 619 FRESENIUS MEDICAL CARE AG: EXPANSIONS
- TABLE 620 FRESENIUS MEDICAL CARE AG: OTHER DEVELOPMENTS
- TABLE 621 DAVITA INC.: COMPANY OVERVIEW
- TABLE 622 DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 623 DAVITA INC.: DEALS
- TABLE 624 VANTIVE: COMPANY OVERVIEW
- TABLE 625 VANTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 626 VANTIVE: PRODUCT LAUNCHES & APPROVALS
- TABLE 627 VANTIVE: DEALS
- TABLE 628 VANTIVE: EXPANSIONS
- TABLE 629 VANTIVE: OTHER DEVELOPMENTS
- TABLE 630 US RENAL CARE, INC.: COMPANY OVERVIEW
- TABLE 631 US RENAL CARE, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 632 B. BRAUN SE: COMPANY OVERVIEW
- TABLE 633 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 634 B. BRAUN SE: EXPANSIONS
- TABLE 635 NIPRO CORPORATION: COMPANY OVERVIEW
- TABLE 636 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 637 NIPRO CORPORATION: PRODUCT LAUNCHES & APPROVALS
- TABLE 638 NIPRO CORPORATION: DEALS
- TABLE 639 NIPRO CORPORATION: EXPANSIONS
- TABLE 640 DIAVERUM AB: COMPANY OVERVIEW
- TABLE 641 DIAVERUM AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 642 DIAVERUM AB: DEALS
- TABLE 643 DIAVERUM AB: EXPANSIONS
- TABLE 644 ASAHI KASEI MEDICAL CO., LTD.: COMPANY OVERVIEW
- TABLE 645 ASAHI KASEI MEDICAL CO., LTD.: PRODUCTS OFFERED
- TABLE 646 ASAHI KASEI MEDICAL CO., LTD.: DEALS
- TABLE 647 ASAHI KASEI MEDICAL CO., LTD.: OTHER DEVELOPMENTS
- TABLE 648 TORAY INDUSTRIES, INC.: COMPANY OVERVIEW
- TABLE 649 TORAY INDUSTRIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 650 NIKKISO CO., LTD.: COMPANY OVERVIEW
- TABLE 651 NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 652 NIKKISO CO., LTD.: PRODUCT LAUNCHES & APPROVALS
- TABLE 653 NIKKISO CO., LTD.: DEALS
- TABLE 654 MOZARC MEDICAL: COMPANY OVERVIEW
- TABLE 655 MOZARC MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 656 MOZARC MEDICAL: DEALS
- TABLE 657 BD: COMPANY OVERVIEW
- TABLE 658 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 659 BD: DEALS
- TABLE 660 BD: EXPANSIONS
- TABLE 661 JMS CO., LTD.: COMPANY OVERVIEW
- TABLE 662 JMS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 663 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
- TABLE 664 MERIT MEDICAL SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 665 MERIT MEDICAL SYSTEMS: DEALS
- TABLE 666 TERUMO CORPORATION: COMPANY OVERVIEW
- TABLE 667 TERUMO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
- TABLE 668 ALLMED MEDICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW
- TABLE 669 OUTSET MEDICAL, INC.: COMPANY OVERVIEW
- TABLE 670 ROCKWELL MEDICAL, INC.: COMPANY OVERVIEW
- TABLE 671 AMERIWATER LLC: COMPANY OVERVIEW
- TABLE 672 DIALIFE SA: COMPANY OVERVIEW
- TABLE 673 QUANTA DIALYSIS TECHNOLOGIES LTD: COMPANY OVERVIEW
- TABLE 674 ISOPURE CORP.: COMPANY OVERVIEW
- TABLE 675 POLY MEDICURE LIMITED: COMPANY OVERVIEW
- TABLE 676 ATLANTIC BIOMEDICAL: COMPANY OVERVIEW
- TABLE 677 AMECATH: COMPANY OVERVIEW
- TABLE 678 STUDY ASSUMPTIONS
- TABLE 679 RISK ASSESSMENT ANALYSIS
List of Figures
- FIGURE 1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SEGMENTATION
- FIGURE 2 MARKET SCENARIO
- FIGURE 3 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2024-2031
- FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2023-2025
- FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET
- FIGURE 6 HIGH-GROWTH SEGMENTS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, 2026-2031
- FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET TRENDS SIGNAL STRONG FUTURE FOR HOME-BASED AND ADVANCED DIALYSIS THERAPIES
- FIGURE 9 INDEPENDENT DIALYSIS CENTERS SEGMENT AND CHINA DOMINATED MARKET IN 2025
- FIGURE 10 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031
- FIGURE 11 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 12 PERCENTAGE OF US ADULTS AGED 18 YEARS AND OLDER WITH CKD, BY AGE, SEX, AND RACE-ETHNICITY
- FIGURE 13 PERCENTAGE OF CKD AMONG US ADULTS WITH DIABETES AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY
- FIGURE 14 PERCENTAGE OF CKD AMONG US ADULTS WITH HIGH BLOOD PRESSURE AGED 18 YEARS OR OLDER, BY AGE, SEX, AND RACE/ETHNICITY
- FIGURE 15 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 16 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 17 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 18 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET ECOSYSTEM
- FIGURE 19 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025 (USD)
- FIGURE 20 AVERAGE SELLING PRICE, BY REGION, 2025 (USD)
- FIGURE 21 REVENUE SHIFT AND NEW REVENUE POCKETS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS DEVICES MARKET
- FIGURE 22 INVESTMENT AND FUNDING SCENARIO
- FIGURE 23 PATENTS APPLIED AND GRANTED, 2015-JUNE 2026
- FIGURE 24 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: AI USE CASES
- FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
- FIGURE 26 KEY BUYING CRITERIA FOR END USERS
- FIGURE 27 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
- FIGURE 28 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT
- FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2023-2025)
- FIGURE 30 GLOBAL HEMODIALYSIS MARKET SHARE, 2025
- FIGURE 31 US HEMODIALYSIS MARKET SHARE, 2025
- FIGURE 32 EUROPE HEMODIALYSIS MARKET SHARE, 2025
- FIGURE 33 GLOBAL PERITONEAL DIALYSIS MARKET SHARE, 2025
- FIGURE 34 US PERITONEAL DIALYSIS MARKET SHARE, 2025
- FIGURE 35 EUROPE PERITONEAL DIALYSIS MARKET SHARE, 2025
- FIGURE 36 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 37 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 38 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (1/2)
- FIGURE 39 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY FOOTPRINT (2/2)
- FIGURE 40 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 42 EV/EBITDA OF KEY VENDORS
- FIGURE 43 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2025)
- FIGURE 44 DAVITA INC.: COMPANY SNAPSHOT (2025)
- FIGURE 45 B. BRAUN SE: COMPANY SNAPSHOT (2025)
- FIGURE 46 NIPRO CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 47 TORAY INDUSTRIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 48 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2025)
- FIGURE 49 BD: COMPANY SNAPSHOT (2025)
- FIGURE 50 JMS CO., LTD.: COMPANY SNAPSHOT (2025)
- FIGURE 51 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025)
- FIGURE 52 TERUMO CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 53 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: RESEARCH DESIGN
- FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
- FIGURE 55 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
- FIGURE 57 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
- FIGURE 58 MARKET SIZE APPROACH - REVENUE SHARE ANALYSIS
- FIGURE 59 REVENUE SHARE ANALYSIS ILLUSTRATION: B BRAUN (2025)
- FIGURE 60 TOP-DOWN APPROACH
- FIGURE 61 BOTTOM-UP APPROACH
- FIGURE 62 DEMAND-SIDE APPROACH
- FIGURE 63 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET (2026-2031)
- FIGURE 64 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
- FIGURE 65 DATA TRIANGULATION METHODOLOGY
02-2729-4219
+886-2-2729-4219
血液透析及腹膜透析市場－2026-2032年全球市場預測腹膜透析市場：按產品類型、療法、患者類型、應用和最終用戶分類－2026-2032年全球市場預測
全球腹膜透析市場（至 2031 年）：按產品（腹膜透析袋/裝置）、治療方法（CAPD）、適應症（末期腎功能衰竭）和最終用戶（醫院）分類
腹膜透析市場規模及預測（2021-2034年），全球及區域佔有率、趨勢和成長機會分析報告：按產品、透析類型、適應症、最終用戶和地區分類
血液透析和腹膜透析市場規模、佔有率和趨勢分析報告：按類型、產品類型、應用、地區和細分市場分類（2026-2033 年）
腹膜透析市場規模、佔有率和成長分析：按設備類型、產品類型、最終用戶、調查方法和地區分類－2026-2033年產業預測
持續性移動式腹膜透析（CAPD）市場規模及預測（2021-2034年），全球及區域佔有率、趨勢和成長機會分析報告：按產品類型、最終用戶和地區分類
自動化腹膜透析市場規模及預測（2021-2034年），全球及區域佔有率、趨勢和成長機會分析報告：按產品、最終用戶和地區分類
腹膜透析市場報告：按治療方法、產品類型、最終用戶和地區分類（2026-2034 年）
腹膜透析市場：按產品類型、應用、最終用戶和地區分類
▼